These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33177621)

  • 21. Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.
    Park HS; Hong SK; Oh MM; Yoon CY; Jeong SJ; Byun SS; Cheon J; Lee SE; Moon du G
    Anticancer Res; 2014 Jul; 34(7):3457-68. PubMed ID: 24982354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition.
    Iqbal A; Eckerdt F; Bell J; Nakano I; Giles FJ; Cheng SY; Lulla RR; Goldman S; Platanias LC
    Oncotarget; 2016 May; 7(22):33192-201. PubMed ID: 27120806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Author Correction: mTOR at the nexus of nutrition, growth, ageing and disease.
    Liu GY; Sabatini DM
    Nat Rev Mol Cell Biol; 2020 Apr; 21(4):246. PubMed ID: 32005970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.
    Kuo CT; Chen CL; Li CC; Huang GS; Ma WY; Hsu WF; Lin CH; Lu YS; Wo AM
    Sci Rep; 2020 Aug; 10(1):14139. PubMed ID: 32811854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Author Correction: Tumours with PI3K activation are resistant to dietary restriction.
    Kalaany NY; Sabatini DM
    Nature; 2020 May; 581(7807):E2. PubMed ID: 32405003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockage of Autophagy Rescues the Dual PI3K/mTOR Inhibitor BEZ235-induced Growth Inhibition of Colorectal Cancer Cells.
    Oh I; Cho H; Lee Y; Cheon M; Park D; Lee Y
    Dev Reprod; 2016 Mar; 20(1):1-10. PubMed ID: 27294206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination treatment of RAD001 and BEZ235 exhibits synergistic antitumor activity via down-regulation of p-4E-BP1/Mcl-1 in small cell lung cancer.
    Hong B; Wang H; Deng K; Wang W; Dai H; Yan Lui VW; Lin W
    Oncotarget; 2017 Dec; 8(63):106486-106498. PubMed ID: 29290965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Author Correction: The evolutionary history of lethal metastatic prostate cancer.
    Gundem G; Van Loo P; Kremeyer B; Alexandrov LB; Tubio JMC; Papaemmanuil E; Brewer DS; Kallio HML; Hägnäs G; Annala M; Kivinummi K; Goody V; Latimer C; O'Meara S; Dawson KJ; Isaacs W; Emmert-Buck MR; Nykter M; Foster C; Kote-Jarai Z; Easton D; Whitaker HC; ; Neal DE; Cooper CS; Eeles RA; Visakorpi T; Campbell PJ; McDermott U; Wedge DC; Bova GS
    Nature; 2020 Aug; 584(7820):E18. PubMed ID: 32728210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Author Correction: Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence.
    Baur ADJ; Hansen CM; Rogasch J; Posch H; Elezkurtaj S; Maxeiner A; Erb-Eigner K; Makowski MR
    Sci Rep; 2020 Mar; 10(1):5249. PubMed ID: 32184409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Author Correction: Anticancer polymers designed for killing dormant prostate cancer cells.
    Takahashi H; Yumoto K; Yasuhara K; Nadres ET; Kikuchi Y; Buttitta L; Taichman RS; Kuroda K
    Sci Rep; 2019 Nov; 9(1):17455. PubMed ID: 31767898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.
    Liu X; Xie C; Li A; Zhang Y; Liu X; Zhou S; Shen J; Huo Z; Cao W; Ma Y; Xu R; Xing Y; Xie Y; Cai S; Tang X
    Am J Transl Res; 2019; 11(12):7255-7271. PubMed ID: 31934276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.
    Adams EJ; Karthaus WR; Hoover E; Liu D; Gruet A; Zhang Z; Cho H; DiLoreto R; Chhangawala S; Liu Y; Watson PA; Davicioni E; Sboner A; Barbieri CE; Bose R; Leslie CS; Sawyers CL
    Nature; 2020 Sep; 585(7826):E20. PubMed ID: 32895534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma.
    Zhu YR; Min H; Fang JF; Zhou F; Deng XW; Zhang YQ
    Cancer Biol Ther; 2015; 16(4):602-9. PubMed ID: 25869769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Author Correction: High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy.
    Zhang X; Sergin I; Evans TD; Jeong SJ; Rodriguez-Velez A; Kapoor D; Chen S; Song E; Holloway KB; Crowley JR; Epelman S; Weihl CC; Diwan A; Fan D; Mittendorfer B; Stitziel NO; Schilling JD; Lodhi IJ; Razani B
    Nat Metab; 2020 Sep; 2(9):991. PubMed ID: 32908252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Author Correction: Evaluation of Radiation dosimetry of
    Zhang J; Zhang J; Xu X; Lu L; Hu S; Liu C; Cheng J; Song S; Zhang Y; Shi LQ
    Sci Rep; 2020 Oct; 10(1):18494. PubMed ID: 33097773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
    Carver BS; Tran J; Gopalan A; Chen Z; Shaikh S; Carracedo A; Alimonti A; Nardella C; Varmeh S; Scardino PT; Cordon-Cardo C; Gerald W; Pandolfi PP
    Nat Genet; 2020 Sep; 52(9):984. PubMed ID: 32820258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
    Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
    Nat Commun; 2020 Feb; 11(1):1095. PubMed ID: 32094369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
    Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
    Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
    Simpson BS; Camacho N; Luxton HJ; Pye H; Finn R; Heavey S; Pitt J; Moore CM; Whitaker HC
    Commun Biol; 2020 Oct; 3(1):570. PubMed ID: 33033409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Author Correction: Mammalian Atg8 proteins and the autophagy factor IRGM control mTOR and TFEB at a regulatory node critical for responses to pathogens.
    Kumar S; Jain A; Choi SW; da Silva GPD; Allers L; Mudd MH; Peters RS; Anonsen JH; Rusten TE; Lazarou M; Deretic V
    Nat Cell Biol; 2020 Oct; 22(10):1286. PubMed ID: 32788721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.